Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheuk-Him Man

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Blood Advances|July 6, 2022
In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependenciesFrancois E Mercier, Jiantao Shi, David B Sykes, et al.
Blood|March 5, 2014
Functions of flt3 in zebrafish hematopoiesis and its relevance to human acute myeloid leukemiaBai-Liang He, Xiangguo Shi, Cheuk Him Man, et al.
Leukemia|May 27, 2022
Regulation of proton partitioning in kinase-activating acute myeloid leukemia and its therapeutic implicationCheuk-Him Man, Xiaoyuan Zeng, Wing Lam, et al.
Blood|February 28, 2012
Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutationCheuk Him Man, Tsz Kan Fung, Christa Ho, et al.
The Journal of Pathology|October 20, 2011
Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinomaCheuk-Him Man, Samantha Wei-Man Lun, Jan Wai-Ying Hui, et al.
Blood|July 26, 2022
Loss of sphingosine kinase 2 promotes the expansion of hematopoietic stem cells by improving their metabolic fitnessChangzheng Li, Binghuo Wu, Yishan Li, et al.
EMBO Molecular Medicine|March 6, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemiaBai-Liang He, Ning Yang, Cheuk Him Man, et al.
Blood|September 22, 2023
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AMLCheuk-Him Man, Wing Lam, Chee-Chean Dang, et al.
Nature Communications|April 6, 2026
Quizartinib and omacetaxine mepesuccinate combination therapy in FLT3-ITD AML: a phase II trialLi-Chuan Zheng, Kelvin K W Wong, Stephen S Y Lam, et al.
Science Translational Medicine|October 7, 2016
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemiaStephen S Y Lam, Eric S K Ho, Bai-Liang He, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood Advances|July 6, 2022
In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependenciesFrancois E Mercier, Jiantao Shi, David B Sykes, et al.
Blood|March 5, 2014
Functions of flt3 in zebrafish hematopoiesis and its relevance to human acute myeloid leukemiaBai-Liang He, Xiangguo Shi, Cheuk Him Man, et al.
Leukemia|May 27, 2022
Regulation of proton partitioning in kinase-activating acute myeloid leukemia and its therapeutic implicationCheuk-Him Man, Xiaoyuan Zeng, Wing Lam, et al.
Blood|February 28, 2012
Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutationCheuk Him Man, Tsz Kan Fung, Christa Ho, et al.
The Journal of Pathology|October 20, 2011
Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinomaCheuk-Him Man, Samantha Wei-Man Lun, Jan Wai-Ying Hui, et al.
Blood|July 26, 2022
Loss of sphingosine kinase 2 promotes the expansion of hematopoietic stem cells by improving their metabolic fitnessChangzheng Li, Binghuo Wu, Yishan Li, et al.
EMBO Molecular Medicine|March 6, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemiaBai-Liang He, Ning Yang, Cheuk Him Man, et al.
Blood|September 22, 2023
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AMLCheuk-Him Man, Wing Lam, Chee-Chean Dang, et al.
Nature Communications|April 6, 2026
Quizartinib and omacetaxine mepesuccinate combination therapy in FLT3-ITD AML: a phase II trialLi-Chuan Zheng, Kelvin K W Wong, Stephen S Y Lam, et al.
Science Translational Medicine|October 7, 2016
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemiaStephen S Y Lam, Eric S K Ho, Bai-Liang He, et al.
Pageof 2